Back to Ovarian Cancer
This trial is complete. It is no longer accepting participants. Results may be available on ClinicalTrials.gov.

NCT05394935

NCT05394935
Completed Not Applicable

Who may be able to join

Who might be able to join this trial:

  • You have been diagnosed with Polycystic Ovary Syndrome (PCOS) using any recognised diagnostic method.
  • You are currently inactive, meaning you do less than 40 minutes of structured exercise per week.

Who may not be able to join:

  • You are currently pregnant or breastfeeding.
  • You have certain hormonal or glandular conditions, including congenital adrenal hyperplasia, Cushing's syndrome, thyroid disease, high prolactin levels (hyperprolactinaemia), or a tumour that produces male hormones (confirm with trial site).
  • You have a known history of heart or cardiovascular disease.
  • You are unable to have an MRI scan because you have metal implants or devices in your body, such as a pacemaker (confirm with trial site).

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

Trial details

Status
Completed
Phase
Not Applicable
Sponsor
Cardiff Metropolitan University
Registry
clinicaltrials_gov
Start date
1 January 2020
Est. completion
25 May 2024

Where this trial is recruiting

🇬🇧 United Kingdom

Primary endpoints

Cerebrovascular Reactivity to Carbon Dioxide (CO2); Cerebrovascular Reactivity to Carbon Dioxide (CO2); Neurovascular coupling (NVC); Neurovascular coupling (NVC); Dynamic cerebral autoregulation (dCA); Dynamic cerebral autoregulation (dCA); Cerebral blood velocity in the middle (MCAv) and posterior cerebral arteries (PCAv) during exercise; Cerebral blood velocity in the middle (MCAv) and posterior cerebral arteries (PCAv) during exercise

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 30 June 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

View original record on ClinicalTrials.gov